✉ Email this page to a colleague
« Back to Dashboard
Methylprednisolone sodium succinateis the generic ingredient in four branded drugs marketed by Abbott, Hospira, Hospira Inc, Elkins Sinn, Organon Usa Inc, Abraxis Pharm, Amneal, Bedford Labs, Eugia Pharma, Fresenius Kabi Usa, Hikma, Intl Medication, Sagent Pharms Inc, Teva Parenteral, Tianjin Kingyork, Watson Labs, and Pharmacia And Upjohn, and is included in forty-eight NDAs. Additional information is available in the individual branded drug profile pages.
There are two drug master file entries for methylprednisolone sodium succinate. Fifteen suppliers are listed for this compound.
Summary for methylprednisolone sodium succinate
|Drug Master File Entries:||2|
|Finished Product Suppliers / Packagers:||15|
|Raw Ingredient (Bulk) Api Vendors:||33|
|Formulation / Manufacturing:||see details|
|What excipients (inactive ingredients) are in methylprednisolone sodium succinate?||methylprednisolone sodium succinate excipients list|
|DailyMed Link:||methylprednisolone sodium succinate at DailyMed|
Recent Clinical Trials for methylprednisolone sodium succinate
Identify potential brand extensions & 505(b)(2) entrants
|Nihon Pharmaceutical Co., Ltd||Phase 3|
|University Children's Hospital Basel||Phase 3|
|University of Roma La Sapienza||Phase 3|